The trademark application for Cancer was filed on July 6, 2011, with 4 designated Nice Classes under EUTM trademark no. 010101293. The trademark was successfully registered on December 9, 2011.
Trademark holder The Board of Regents, The University of Texas System was represented by CHARLES RUSSELL SPEECHLYS LLP (EUIPO registered representative, ID no. 42054).
No oppositions were raised during the publication period (90 days starting September 1, 2011).
Current trademark registration will expire on July 6, 2021.
|Trademark Name||Cancer||Trademark No.||010101293|
|Filling Date||July 6, 2011||Registration Date||December 9, 2011|
|NICE Classes||35, 36, 41, 44||Basis||EUTM|
|Reference||RM.JH.L1234-00065.JG||Status Date||December 13, 2011|
|Owner||The Board of Regents, The University of Texas System|
|Legal Status||Legal entity|
|Address||The Board of Regents, The University of Texas System
201 West 7th Street
Austin, Texas 78701
|Representative||CHARLES RUSSELL SPEECHLYS LLP|
|Legal Status||Legal person|
|Address||CHARLES RUSSELL SPEECHLYS LLP
5 Fleet Place
London EC4M 7RD
Advertising, Business Consulting
Consulting services, namely, consulting on the establishment, management, and operation of cancer treatment centers.
Charitable fund raising services.
Education, Amusement, Entertainment, Reproduction
Educational services, namely, conducting programs, seminars, lectures and workshops in the fields of medicine and healthcare relating to cancer and cancer prevention and early detection, and distribution of printed materials therewith; educational services, namely, developing and disseminating educational materials via online and kiosk-based interactive programs in the fields of cancer and cancer prevention; educational services, namely, developing and disseminating educational materials and programs to physicians and patients regarding cancer and other diseases, oncology and disease management.
Medical services; veterinary services; hygienic and beauty care for human beings or animals.
Medical services relating to cancer; medical services, namely, radiation oncology services; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, utilization review, counseling, and patient networking; consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, utilization review, and patient care management; computer information services, namely, providing information on cancer and other diseases, oncology and disease management via a global computer network; medical research services; medical services, namely, medical diagnostic testing, monitoring and reporting services; medical imaging services; medical radiology services; nuclear medical services.
Disclaimer: The information provided on this page is considered public information by the European Union Intellectual Property Office and is provided for informational purposes only. It should not be construed as legal advice on any subject matter.